Zai Lab Partner Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-3 Trial of KarXT in Schizophrenia
Mar 20, 2023
Read MoreZai Lab Statement on Silicon Valley Bank (“SVB”) and Joint US Federal Agency Announcement
Mar 12, 2023
Read MoreZai Lab Announces Full-Year 2022 Financial Results and Recent Corporate Updates
Mar 01, 2023
Read MoreZai Lab to Present Two New Phase 3 Analyses for Niraparib in Ovarian Cancer at the 2023 ESMO Gynaecological Cancers Congress
Feb 22, 2023
Read MoreZai Lab Announces NDA Acceptance of Sulbactam-Durlobactam (SUL-DUR) for Infections Caused by Acinetobacter baumannii in China by the NMPA
Feb 22, 2023
Read MoreZai Lab to Announce Full-Year Financial Results and Corporate Updates on March 1, 2023
Feb 09, 2023
Read More